Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell-cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumour effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumours in mice models, and they are effective in the treatment of promyelocytic leukemia. Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA. The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition. The residues that make up the active site and contact the inhibitors are conserved across the HDAC family. These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumour agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conformation of this loop is virtually identical in the three HDLP structures (Finnin et al., 1999), suggesting that the surface of HDLP is less malleable than that of HDAC8 around the binding site pocket.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“The apparent reduced flexibility in the HDLP surface may also explain why it is less efficient in histone deacetylase assays (Finnin et al., 1999).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“Finnin et al. (1999) have suggested that H143 protonates the lysine after the carbon-nitrogen scissile bond breaks.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
[26] Raster3D: Photorealistic molecular graphics
Merritt, E. A., & Bacon, D. J. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77028-9 · Cited by 3,739
The relation between the divergence of sequence and structure in proteins.
Chothia, C., & Lesk, A. M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04288.x · Cited by 2,458
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus
Deckert, G., Warren, P. V., Gaasterland, T., Young, W. G., Lenox, A. L., Graham, D. E., Overbeek, R., Snead, M. A., Keller, M., Aujay, M., et al. (1998) · Nature · doi:10.1038/32831 · Cited by 1,097
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Self-citation
Research works printed but not linked: 2
- Cohen,L. A. et al. Inhibition of N-methylnitrosourea-induced tumours by the cytodifferentiating agent, suberanilohydroxamic acid (SAHA). Proc. AACR 39, 108, abstr. 736 (1998).
- Desai,D., El-Bayoumy,K. & Amin,S. Chemopreventive efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylinitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. Proc. AACR 40, 2396, abstr. 362 (1999).
Cited by
Items 601–700 of 1,007
Cao, B., Li, J., Zhu, J., Shen, M., Han, K., Zhang, Z., Yu, Y., Wang, Y., Wu, D., Chen, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.472563 · Cited by 55
Salmi, C., Fabre, A. J., Dequiedt, F., Restouin, A., Castellano, R., Garbit, S., Roche, P., Morelli, X., Brunel, J. M., & Collette, Y. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901358y · Cited by 55
Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Yang, Y., Kim, H., Li, W., & Kong, A. T. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150826114359 · Cited by 55
3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues
Juvale, D. C., Kulkarni, V. V., Deokar, H. S., Wagh, N. K., Padhyé, S., & Kulkarni, V. M. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b606365a · Cited by 55
Identification of novel small molecule enhancers of protein production by cultured mammalian cells
Allen, M. J., Boyce, J. P., Trentalange, M. T., Treiber, D. L., Rasmussen, B., Tillotson, B., Davis, R., & Reddy, P. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21839 · Cited by 54
Wang, D. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609788085287 · Cited by 54
Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster
Chen, T., Sun, H., Lü, J., Zhao, Y., Tao, D., Li, X., & Huang, B. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00564-7 · Cited by 54
Histone deacetylase inhibition in the treatment of heart disease
Berry, J. M., Cao, D. J., Rothermel, B. A., & Hill, J. A. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.1.53 · Cited by 54
Lakshmikanthan, V., Kaddour‐Djebbar, I., Lewis, R. W., & Kumar, M. V. (2006) · International Journal of Cancer · doi:10.1002/ijc.21824 · Cited by 54
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival
Flørenes, V. A., Skrede, M. L., Jørgensen, K., & Nesland, J. M. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000129576.49313.26 · Cited by 54
The Molecular Basis of Toxins’ Interactions with Intracellular Signaling via Discrete Portals
Lahiani, A., Yavin, E., & Lazarovici, P. (2017) · Toxins · doi:10.3390/toxins9030107 · Cited by 54
Fu, J., Yang, Y., Zhang, X., Mao, W.-J., Zhang, Z., & Zhu, H. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.10.049 · Cited by 54
Design and synthesis of phthalimide-type histone deacetylase inhibitors
Shinji, C., Nakamura, T., Maeda, S., Yoshida, M., Hashimoto, Y., & Miyachi, H. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.048 · Cited by 54
Butt, N. A., Kumar, A., Dhar, S., Rimando, A. M., Akhtar, I., Hancock, J. C., Lage, J. M., Pound, C. R., Lewin, J. R., Gómez, C. R., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1209 · Cited by 54
Elaut, G., Török, G., Vinken, M., Laus, G., Papeleu, P., Tourwé, D., & Rogiers, V. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1320 · Cited by 53
Eyal, S., Yagen, B., Shimshoni, J. A., & Bialer, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.012 · Cited by 53
Recent Advances in Cancer Therapeutics
Chessum, N. E. A., Jones, K., Pasqua, E., & Tucker, M. (2015) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2014.11.002 · Cited by 53
Mai, A., Massa, S., Rotili, D., Pezzi, R., Bottoni, P., Scatena, R., Meraner, J., & Brosch, G. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.081 · Cited by 53
The Epigenetic Modifier, Valproic Acid, Enhances Radiation Sensitivity
Karagiannis, T. C., Kurup, H. K. N., & El‐Osta, A. (2006) · Epigenetics · doi:10.4161/epi.1.3.2896 · Cited by 53
HDAC6 Is Overexpressed in Cystic Cholangiocytes and Its Inhibition Reduces Cystogenesis
Gradilone, S. A., Habringer, S., Masyuk, T. V., Howard, B. N., Masyuk, A. I., & LaRusso, N. F. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.027 · Cited by 53
Kang, K. A., Piao, M. J., Kim, K. C., Zheng, J., Yao, C. W., CHA, J. W., Kim, H. S., Kim, D. H., Bae, S. C., & Hyun, J. W. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2129 · Cited by 53
Lan, H., Wu, L., Sun, R., Keller, N. P., Yang, K., Ye, L., He, S., Zhang, F., & Wang, S. (2019) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-01-19-0033-r · Cited by 53
Ganai, S. A. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.130 · Cited by 53
Kinetic Analysis of the Zinc-Dependent Deacetylase in the Lipid A Biosynthetic Pathway
McClerren, A. L., Zhou, P., Guan, Z., Raetz, C. R. H., & Rudolph, J. (2005) · Biochemistry · doi:10.1021/bi048001h · Cited by 53
Wambua, M. K., Nalawansha, D. A., Negmeldin, A. T., & Pflum, M. K. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401837e · Cited by 52
The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase
Zhang, X., Bao, B., Yu, X., Tong, L., Luo, Y., Huang, Q., Su, M., Li, S., Li, J. X., Zhu, H., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.023 · Cited by 52
Small-Molecule Suppressors of Cytokine-Induced β-Cell Apoptosis
Chou, D. H., Bodycombe, N. E., Carrinski, H. A., Lewis, T. A., Clemons, P. A., Schreiber, S. L., & Wagner, B. K. (2010) · ACS Chemical Biology · doi:10.1021/cb100129d · Cited by 52
Giannini, G., Vesci, L., Battistuzzi, G., Vignola, D., Milazzo, F. M., Guglielmi, M. B., Barbarino, M., Santaniello, M., Fantò, N., Mor, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008209 · Cited by 52
Thangapandian, S., John, S., Lee, Y., Kim, S., & Lee, K. W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129440 · Cited by 52
Rapino, F. A., Jung, M., & Fulda, S. (2013) · Oncogene · doi:10.1038/onc.2013.110 · Cited by 52
Emerging molecular therapies of advanced thyroid cancer
Catalano, M. G., Poli, R., Pugliese, M., Fortunati, N., & Boccuzzi, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.006 · Cited by 52
Sharma, A., Anumanthan, G., Reyes, M., Chen, H., Brubaker, J. W., Siddiqui, S., Gupta, S., Rieger, F. G., & Mohan, R. R. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18750 · Cited by 52
Bioactive heterocycles containing endocyclic N-hydroxy groups
Rani, R., & Granchi, C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.031 · Cited by 52
The Role of FOXP3 in Regulating Immune Responses
Vent‐Schmidt, J., Han, J. M., MacDonald, K. G., & Levings, M. K. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.811657 · Cited by 51
Pentanoic Acid, a Novel Protein Synthesis Stimulant for Chinese Hamster Ovary(CHO) Cells.
Liu, C., Chu, I., & Hwang, S. (2001) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(01)80114-6 · Cited by 51
Kozikowski, A. P., Chen, Y., Gaysin, A. M., Savoy, D. N., Billadeau, D. D., & Kim, K. H. (2008) · ChemMedChem · doi:10.1002/cmdc.200700314 · Cited by 51
Hildmann, C., Ninkovic, M., Dietrich, R., Wegener, D., Riester, D., Zimmermann, T., Birch, O. M., Bernegger, C., Loidl, P., & Schwienhorst, A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.8.2328-2339.2004 · Cited by 51
Drug Discovery and Chemical Biology of Cancer Epigenetics
Ribich, S. A., Harvey, D. M., & Copeland, R. A. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.020 · Cited by 51
Calonghi, N., Cappadone, C., Pagnotta, E., Boga, C., Bertucci, C., Fiori, J., Tasco, G., Casadio, R., & Masotti, L. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400424-jlr200 · Cited by 51
Perez, M. H., Shao, Q., Yang, X., Luh, S., Kandouz, M., Batist, G., Laird, D. W., & Alaoui‐Jamali, M. A. (2006) · The Prostate · doi:10.1002/pros.20451 · Cited by 51
Rodriquez, M., Terracciano, S., Cini, E., Settembrini, G., Bruno, I., Bifulco, G., Taddei, M., & Gomez‐Paloma, L. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200501995 · Cited by 51
Campbell, C. T., Aich, U., Weier, C. A., Wang, J. J., Choi, S. S., Wen, M. M., Maisel, K., Sampathkumar, S., & Yarema, K. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800873k · Cited by 51
Quantitative Assays for Characterization of the Sir2 Family of NAD+-Dependent Deacetylases
Borra, M. T., & Denu, J. M. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)76011-x · Cited by 50
Arabidopsis histone deacetylase 6: a green link to RNA silencing
Aufsatz, W., Stoiber, T., Rakic, B., & Naumann, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210615 · Cited by 50
Lombardi, P. M., Angell, H. D., Whittington, D. A., Flynn, E. F., Rajashankar, K. R., & Christianson, D. W. (2011) · Biochemistry · doi:10.1021/bi101859k · Cited by 50
Targeted deletion of NF-κB p50 diminishes the cardioprotection of histone deacetylase inhibition
Zhang, L., Zhao, Y., Cheng, G., Guo, T. L., Chin, Y. E., Liu, P. Y., & Zhao, T. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01015.2009 · Cited by 50
Abdizadeh, R., Hadizadeh, F., & Abdizadeh, T. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.126961 · Cited by 50
Indole amide hydroxamic acids as potent inhibitors of histone deacetylases
Dai, Y., Guo, Y. P., Guo, J., Pease, L. J., Li, J., Marcotte, P. A., Glaser, K. B., Tapang, P., Albert, D. H., Richardson, P. L., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00301-9 · Cited by 50
Bruserud, Ø., Stapnes, C., Tronstad, K. J., Ryningen, A., Ånensen, N., & Gjertsen, B. T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.51 · Cited by 49
Gu, W., Nusinzon, I., Smith, R. D., Horvath, C. M., & Silverman, R. B. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.047 · Cited by 49
Sixto‐López, Y., Bello, M., & Correa‐Basurto, J. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1441072 · Cited by 49
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors
Hamblett, C. L., Methot, J. L., Mampreian, D. M., Sloman, D. L., Stanton, M. G., Kral, A. M., Fleming, J. C., Cruz, J. C., Chénard, M., Ozerova, N. D. S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.023 · Cited by 49
Gupta, S. P. (2015) · Chemical Reviews · doi:10.1021/cr500483r · Cited by 49
Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome
Yang, L., Chen, J., Shi, L., Hudock, M. P., Wang, K., & He, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009568 · Cited by 49
A Class 1 Histone Deacetylase with Potential as an Antifungal Target
Bauer, I., Varadarajan, D., Pidroni, A., Gross, S., Vergeiner, S., Faber, B., Hermann, M., Tribus, M., Brosch, G., & Graessle, S. (2016) · mBio · doi:10.1128/mbio.00831-16 · Cited by 49
de Freitas, N. L., Deberaldini, M. G., Gomes, D., Pavan, A. R., Sousa, Â., dos Santos, J. L., & Soares, C. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.592868 · Cited by 49
Interpreting clinical assays for histone deacetylase inhibitors
Bertrand, P., & Martinet, N. (2011) · Cancer Management and Research · doi:10.2147/cmr.s9661 · Cited by 49
An Overview of the Molecular Basis of Epigenetics
Sweatt, J. D., Nestler, E. J., Meaney, M. J., & Akbarian, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391494-1.00001-x · Cited by 49
HDAC inhibition ameliorates cone survival in retinitis pigmentosa mice
Samardzija, M., Corna, A., Gomez-Sintes, R., Jarboui, M. A., Armento, A., Roger, J. E., Petridou, E., Haq, W., Paquet-Durand, F., Zrenner, E., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00653-3 · Cited by 48
Towards the quantum-enabled technologies for development of drugs or delivery systems
Hassanzadeh, P. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.050 · Cited by 48
Dai, Y., Guo, Y. P., Curtin, M. L., Li, J., Pease, L. J., Guo, J., Marcotte, P. A., Glaser, K. B., Davidsen, S. K., & Michaelides, M. R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.012 · Cited by 48
Yan, C., Xiu, Z., Li, X., Li, S., Hao, C., & Teng, H. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22047 · Cited by 48
Bispyridinium Dienes: Histone Deacetylase Inhibitors with Selective Activities
Pérez-Balado, C., Nebbioso, A., Rodríguez-Graña, P., Minichiello, A., Miceli, M., Altucci, L., & de Lera, Á. R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070028m · Cited by 48
Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase
Finn, P. W., Bandara, M., Butcher, C., Finn, A., Hollinshead, R., Khan, N., Law, N. M., Murthy, S., Romero, R., Watkins, C., et al. (2005) · Helvetica Chimica Acta · doi:10.1002/hlca.200590129 · Cited by 48
Peng, F.-W., Wu, T.-T., Ren, Z., Xue, J., & Shi, L. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.006 · Cited by 48
Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes
Kalyaanamoorthy, S., & Chen, Y. P. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.009 · Cited by 48
3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment
Chen, Y., Li, H., Tang, W., Zhu, C., Jiang, Y., Zou, J., Yu, Q., & You, Q. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.12.008 · Cited by 48
Insights Into the Function and Clinical Application of HDAC5 in Cancer Management
Yang, J., Gong, C., Ke, Q., Fang, Z., Chen, X., Ye, M., & Xi Tao, X. U. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.661620 · Cited by 48
Kim, D.-K., Lee, J. Y., Kim, J.-S., Ryu, J.-H., Choi, J.-Y., Lee, J., Im, G.-J., Kim, T.-K., Seo, J. W., Park, H., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030377q · Cited by 48
Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells
Yang, H., Nie, Y., Li, Y., & Wan, Y. Y. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009252 · Cited by 48
Boissinot, M., Inman, M., Hempshall, A., James, S. R., Gill, J. H., Selby, P., Bowen, D. T., Grigg, R., & Cockerill, P. N. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.07.002 · Cited by 47
Histone deacetylase-mediated morphological transition in Candida albicans
Kim, J., Lee, J., & Lee, J. (2015) · The Journal of Microbiology · doi:10.1007/s12275-015-5488-3 · Cited by 47
Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective
Patel, V. K., Shirbhate, E., Tiwari, P., Kore, R., Veerasamy, R., Mishra, A., & Rajak, H. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220922105615 · Cited by 47
Thomas, M., Rivault, F., Tranoy‐Opalinski, I., Roche, J., Gesson, J., & Papot, S. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.042 · Cited by 47
Epigenetik – ein Epizentrum der Genregulation: Histone und histonmodifizierende Enzyme
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie · doi:10.1002/ange.200461346 · Cited by 47
Upregulation of Nerve Growth Factor in Central Amygdala Increases Sensitivity to Opioid Reward
Bie, B., Wang, Y., Cai, Y.-Q., Zhang, Z., Hou, Y.-Y., & Pan, Z. Z. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.144 · Cited by 47
Trichostatin A and sodium butyrate promotes plant regeneration in common wheat
Bie, X. M., Dong, L., Li, X. H., Wang, H., Gao, X.-Q., & Li, X. G. (2020) · Plant Signaling & Behavior · doi:10.1080/15592324.2020.1820681 · Cited by 47
Liu, J., Meng, H., Li, S., Shen, Y., Wang, H., Wu, S., Qiu, J., Zhang, J., & Cheng, W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01031 · Cited by 47
Maeda, Y., Seidel, S. D., Wei, G., Liu, X., & Sladek, F. M. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.2.0769 · Cited by 47
Hou, J., Li, Z., Fang, Q., Feng, C., Zhang, H., Guo, W., Wang, H. H., Gu, G., Tian, Y., Liu, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201496g · Cited by 47
de Ruijter, A. J. M., Kemp, S., Kramer, G., Meinsma, R., Kaufmann, J. O., Caron, H. N., & Kuilenburg, A. B. P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.010 · Cited by 47
Stability studies of vorinostat and its two metabolites in human plasma, serum and urine
Du, L., Musson, D. G., & Wang, A. Q. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.05.005 · Cited by 47
Kosugi, H., Ito, M., Yamamoto, Y., Towatari, M., Ito, M., Ueda, R., Saito, H., & Naoe, T. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01126.x · Cited by 46
Trithiocarbonates—Exploration of a new head group for HDAC inhibitors
Dehmel, F., Ciossek, T., Maier, T. M., Weinbrenner, S., Schmidt, B. G., Zoche, M., & Beckers, T. L. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.063 · Cited by 46
Natural and Synthetic Macrocyclic Inhibitors of the Histone Deacetylase Enzymes
Maolanon, A. R., Kristensen, H. M. E., Leman, L. J., Ghadiri, M. R., & Olsen, C. A. (2017) · ChemBioChem · doi:10.1002/cbic.201600519 · Cited by 46
Mustafa, A. M., & Krämer, O. H. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000612 · Cited by 46
Chen, S., Zhao, Y., Gou, W., Zhao, S., Takano, Y., & Zheng, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079781 · Cited by 46
Raucci, A., Zwergel, C., Valente, S., & Mai, A. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01677 · Cited by 46
Karagiannis, T. C., & El‐Osta, A. (2006) · Epigenetics · doi:10.4161/epi.1.3.3328 · Cited by 46
A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors
Dickson, M. A., Rathkopf, D. E., Carvajal, R. D., Grant, S., Roberts, J. D., Reid, J. M., Ames, M. M., McGovern, R. M., Lefkowitz, R. A., Gönen, M., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9447-x · Cited by 46
Panobinostat in lymphoid and myeloid malignancies
Khot, A. S., Dickinson, M. J., & Prince, H. M. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.815165 · Cited by 46
Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis
Rensvold, J. W., Krautkramer, K. A., Dowell, J. A., Denu, J. M., & Pagliarini, D. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.727701 · Cited by 45
Design and Solution Structure of Functional Peptide Mimetics of Nerve Growth Factor
Beglova, N., Maliartchouk, S., Ekiel, I. H., Zaccaro, M. C., Saragovi, H. U., & Gehring, K. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990441x · Cited by 45
Cai, J., Wei, H., Hong, K. H., Wu, X., Zong, X., Cao, M., Wang, P., Li, L., Sun, C., Chen, B., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.028 · Cited by 45
Aboeldahab, A. M. A., Beshr, E. A. M., Shoman, M. E., Rabea, S. M., & Aly, O. M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.021 · Cited by 45
Ragno, R., Simeoni, S., Rotili, D., Caroli, A., Botta, G., Brosch, G., Massa, S., & Mai, A. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.05.004 · Cited by 45
Rudolph, M. G., Heißmann, R., Wittmann, J., & Klostermeier, D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.065 · Cited by 45
Loss of NKX3.1 Favors Vascular Endothelial Growth Factor-C Expression in Prostate Cancer
Zhang, H., Muders, M. H., Li, J., Rinaldo, F. M., Tindall, D. J., & Datta, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1912 · Cited by 45
Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors
Loudni, L., Roche, J., Potiron, V. A., Clarhaut, J. A., Bachmann, C., Gesson, J., & Tranoy‐Opalinski, I. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.067 · Cited by 45
Small-molecular modulators of cancer-associated epigenetic mechanisms
Itoh, Y., Suzuki, T., & Miyata, N. (2013) · Molecular BioSystems · doi:10.1039/c3mb25410k · Cited by 44
Metadata
- Authors
- Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Columbia University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Nature
- Published
- 1999-09
- Volume
- 401
- Issue
- 6749
- Pages
- 188-193
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2135830745
- Cited by
- 1,714
- References
- 28
- Citations by year
- 2026: 39 · 2025: 48 · 2024: 40 · 2023: 55 · 2022: 28 · 2021: 66 · 2020: 62 · 2019: 50 · 2018: 52 · 2017: 70 · 2016: 68 · 2015: 74 · 2014: 67 · 2013: 78 · 2012: 82
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase, histone deacetylase inhibitors, trichostatin A, vorinostat, Aquifex aeolicus, crystal structure, catalytic site, zinc binding site, hyperthermophilic bacteria, anticancer agents, promyelocytic leukemia
- MeSH terms
- Vorinostat, Amino Acid Sequence, Enzyme Inhibitors, Escherichia coli, Histone Deacetylases, Humans, Hydroxamic Acids, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Recombinant Fusion Proteins, Zinc, Gram-Negative Aerobic Rods and Cocci, Sequence Homology, Amino Acid, Crystallography, X-Ray, Catalytic Domain, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.